858855-11-5 Usage
General Description
5-Bromo-2-iodophenol, also known as 2-bromo-5-iodophenol, is a chemical compound with the molecular formula C6H4BrIO. It is a derivative of phenol, containing both bromine and iodine substituents on the aromatic ring. 5-Bromo-2-iodophenol is commonly used as a reagent and building block in organic chemistry, particularly in the synthesis of complex molecules such as pharmaceuticals and natural products. It has been utilized in the preparation of various biologically active compounds and as a precursor in the development of new drugs. Additionally, 5-Bromo-2-iodophenol has potential applications in materials science, particularly in the fabrication of functional organic materials. 5-Bromo-2-iodophenol is available commercially and is typically handled in accordance with safe laboratory practices due to its potential toxic and hazardous properties.
Check Digit Verification of cas no
The CAS Registry Mumber 858855-11-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,8,8,5 and 5 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 858855-11:
(8*8)+(7*5)+(6*8)+(5*8)+(4*5)+(3*5)+(2*1)+(1*1)=225
225 % 10 = 5
So 858855-11-5 is a valid CAS Registry Number.
858855-11-5Relevant articles and documents
Synthesis of an organic-soluble π-conjugated [3]rotaxane via rotation of glucopyranose units in permethylated β-cyclodextrin
Terao, Jun,Konoshima, Yohei,Matono, Akitoshi,Masai, Hiroshi,Fujihara, Tetsuaki,Tsuji, Yasushi
, p. 2800 - 2808 (2014)
We synthesized symmetrically insulated oligo(para-phenylene) and oligothiophene with a pseudo-linked [3]rotaxane structure by full rotation of glucopyranose units via a flipping (tumbling) mechanism in the π-conjugated guest having two permethylated β-cyc
1-(CHLOROMETHYL)-2,3-DIHYDRO-1H-BENZO[E]INDOLE DIMER ANTIBODY-DRUG CONJUGATE COMPOUNDS, AND METHODS OF USE AND TREATMENT
-
Page/Page column 162, (2015/02/25)
The invention provides antibody-drug conjugates comprising an antibody conjugated to a 1-(chloromethyl)-2,3-dihydro-1H-benzo[e]indole (CBI) dimer drug moiety via a linker, and methods of using the antibody-drug conjugates.
